Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors (Q57216049)
Jump to navigation
Jump to search
scientific article published on 07 December 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors |
scientific article published on 07 December 2017 |
Statements
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors (English)
Christine M Lovly
Anil Betigeri
Kalyanasundaram Subramanian
Jeffrey S Ross
Dean C Pavlick
Siraj Ali
Paul Markowski
Ann Silk
Howard L Kaufman
Edmund Lattime
Janice M Mehnert
Ryan Sullivan
Jeffrey Sosman
Douglas B Johnson
Gyan Bhanot
1 reference